Cancer Research UK logo
Therapeutic Catalyst

Therapeutic Catalyst

Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.

OpenCancer Research UK
View on funder site
About

Cancer Research UK's Therapeutic Catalyst scheme accelerates the translation of laboratory discoveries into novel cancer therapeutics by funding exploratory drug discovery projects focused on validating and de-risking therapeutic targets. Awards of up to £250,000 are available over up to 18 months and cover external resources, outsourced activities, staff time, and running expenses. As an AMRC mem…

What this grant funds

Cancer therapeutic target identification, deconvolution, and validation, plus feasibility work on novel therapeutic approaches to validated targets, conducted in collaboration with Cancer Research Horizons.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.25 Sept 2026
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.18 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
What you have to submit

Sign up free to see what you submit

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 22 Jul 2026Source: find.cancerresearchuk.org